MCM
NUVB icon

Massar Capital Management’s Nuvation Bio NUVB Stock Holding History

Massar Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-54,717
Closed -$202K – 355
2025
Q3 		$202K Hold
54,717
– – 0.03% 172
2025
Q2 		$107K Buy
+54,717
New +$114K 0.08% 110

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Massar Capital Management's NUVB Position: Q4 2025 in Review

Massar Capital Management sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 54,717 shares — an estimated $202K sold.

Massar Capital Management first reported a position in NUVB in Q2 2025 and held it in 2 quarters. The position peaked at $202K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Massar Capital Management reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • Massar Capital Management sold 54,717 Nuvation Bio shares in Q4 2025, an estimated $202K.
  • Massar Capital Management first reported a position in Nuvation Bio in Q2 2025 and held it in 2 quarters.
  • Massar Capital Management's Nuvation Bio position peaked at $202K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Massar Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.